EXPO
EXPONENT INC
NASDAQ · Industrials · Consulting Services · US
$87.02
+1.22%Year over year
Reported trailing growth
- Revenue
- +15.4%
- EBITDA
- +2.1%
- EBIT
- +19.1%
- EPS
- +13.2%
- Free cash flow
- -0.5%
- Operating cash flow
- -0.4%
Forward estimates
Based on analyst estimates
- Revenue
- -4.4%
- EBITDA
- +11.6%
- EPS
- +11.2%
Three-year CAGR
- Revenue
- +4.3%
- EBITDA
- +4.1%
- EBIT
- -5.3%
- Net income
- +1.2%
- EPS
- +1.7%
- Free cash flow
- +14.4%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Oct 1, 2026